Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Odra Martínez-González"'
Autor:
Luz Tarín-Arzaga, Carlos de la Cruz-de la Cruz, Omar Cantu-Martinez, Odra Martínez-González, David Gómez-Almaguer
Publikováno v:
Medicina Universitaria, Vol 25, Iss 2 (2023)
During the development of a previous study recently published in this journal, where we sought to establish a serum globulins cutoff measured on routinely performed liver function tests for screening monoclonal gammopathies (MG)1, it was suggested to
Externí odkaz:
https://doaj.org/article/ae31c430e7dd4e2fa49b628a5a376a9d
Publikováno v:
Medicina Universitaria, Vol 24, Iss 1 (2022)
Background: Monoclonal gammopathies are a group of disorders characterized by an overproduction of monoclonal immunoglobulin. Detection and quantification of monoclonal components using serum protein electrophoresis (SPE) for screening is the initial
Externí odkaz:
https://doaj.org/article/461b1d447f6a4ef78a42b5af17a37d87
Autor:
Luz Tarín-Arzaga, Carlos de la Cruz-de la Cruz, Martha A. Reyes-López, Omar Cantu-Martinez, Karina Vázquez-Hernández, Odra Martínez-González, Luis A. González-Torres, Luis J. Marfil-Rivera, David Gómez-Almaguer
Publikováno v:
Medicina Universitaria, Vol 23, Iss 1 (2021)
Lupus anticoagulant (LA) is a heterogeneous group of antibodies that interfere with phospholipid-dependent coagulation tests, which result in abnormally prolonged clotting times in vitro. The prevalence of LA in a healthy individual is 1-5%1,2.
Externí odkaz:
https://doaj.org/article/9d4a03b97ebb4a9da4202e6a3f9048a9
Autor:
Martha A. Reyes-López, Karina Elizabeth Vázquez-Hernández, Luis A. González-Torres, Odra Martínez-González, Luz Tarín-Arzaga, Luis Javier Marfil-Rivera, David Gómez-Almaguer, Carlos de la Cruz-de la Cruz, Omar Cantú-Martínez
Publikováno v:
Medicina Universitaria, Vol 23, Iss 1 (2021)
Lupus anticoagulant (LA) is a heterogeneous group of antibodies that interfere with phospholipid-dependent coagulation tests, which result in abnormally prolonged clotting times in vitro. The prevalence of LA in a healthy individual is 1-5%1,2.
Autor:
César Homero Gutiérrez-Aguirre, Andrés Gómez-De León, José Carlos Jaime-Pérez, Daniela Arredondo-Campos, Olga G. Cantú-Rodríguez, Victor Martínez-Pacheco, Odra Martínez-González, David Gómez-Almaguer, Alba Ramírez-López, Luz Tarín-Arzaga
Publikováno v:
Cancer. 124:1946-1953
BACKGROUND The treatment of multiple myeloma (MM) has become costly and difficult to access for patients living in low-income to middle-income countries. METHODS The current retrospective study included 148 patients in Mexico with newly diagnosed MM,
Autor:
Luz, Tarín-Arzaga, Daniela, Arredondo-Campos, Victor, Martínez-Pacheco, Odra, Martínez-González, Alba, Ramírez-López, Andrés, Gómez-De León, Cesar Homero, Gutiérrez-Aguirre, Olga, Cantú-Rodríguez, José Carlos, Jaime-Pérez, David, Gómez-Almaguer
Publikováno v:
Cancer. 124(9)
The treatment of multiple myeloma (MM) has become costly and difficult to access for patients living in low-income to middle-income countries.The current retrospective study included 148 patients in Mexico with newly diagnosed MM, and was performed t
Autor:
Rosario Salazar-Riojas, Olga G. Cantú-Rodríguez, Oscar González-Llano, David Gómez-Almaguer, Guillermo J Ruiz-Argüelles, José Carlos Jaime-Pérez, Luz Tarín-Arzaga, César Homero Gutiérrez-Aguirre, Amelia Morales-Toquero, Odra Martínez-González
Publikováno v:
Hematology. 12:193-197
Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective strategy for preventing relapse of acute myelogenous leukemia (AML). We analyzed the outcome of 31 primary AML patients who received a reduced-intensity conditioning regimen fo
Autor:
Rosario, Salazar-Riojas, José Alberto, García-Lozano, Mayra, Valdés-Galván, Odra, Martínez-González, Olga Graciela, Cantú-Rodríguez, Oscar, González-Llano, Andrés, Gómez-De León, José Carlos, Jaime-Pérez, David, Gómez-Almaguer, César Homero, Gutiérrez-Aguirre
Publikováno v:
Journal of clinical apheresis. 30(5)
Peripheral blood stem cell (PBSC) transplantation has become a routine procedure in pediatric oncology. A special group of PBSC donors are children weighing 20 kg or less. Limited vascular access and low blood volume puts them at a higher risk. Centr
Autor:
David Gómez-Almaguer, Guillermo J. Ruiz-Delgado, K.I. Gutierrez-Riverol, Rosario Salazar-Riojas, César Homero Gutiérrez-Aguirre, Odra Martínez-González, Guillermo J Ruiz-Argüelles, Olga G. Cantú-Rodríguez, Oscar González-Llano, José Carlos Jaime-Pérez
Publikováno v:
Biology of Blood and Marrow Transplantation. 15(2)
Autor:
César Homero Gutiérrez-Aguirre, Oscar González-Llano, José Carlos Jaime-Pérez, David Gómez-Almaguer, Odra Martínez-González, Rosario Salazar-Riojas, Olga G. Cantú-Rodríguez
Publikováno v:
Biology of Blood and Marrow Transplantation. 11(2)